3 latest FDA approvals

Here are the three latest drugs or medical devices approved by the FDA this week.

Advertisement

1. Imfinzi is used to treat patients with inoperable, midstage non-small cell lung cancer that has not metastasized throughout the body.

2. Osmolex may be used to treat patients with Parkinson’s disease or drug-induced movement disorders.

3. The Trevo Retriever, a clot-removal device, may now be used as a first-line treatment for stroke patients for up to 24 hours after symptom onset. 

More articles on supply chain:
Pharma deals in an era of heightened competition: 6 recent drugmaker transactions, partnerships
Recognize 5 types of supply chain leaders in your hospital
Merck to purchase Viralytics for $394M: 3 things to know

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.